MTOR and cystic fibrosis: Previous studies have demonstrated that mTOR inhibitors reduce inflammation in cystic fibrosis (CF)80–82, while reduced ubiquitin-mediated proteolysis has been linked to decreased inflammation and increased CFTR cell surface expression83,84.